These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30884127)

  • 41. Expression of HIF-1α and HIF-2α correlates to biological and clinical significance in papillary thyroid carcinoma.
    Liu YM; Ying SP; Huang YR; Pan Y; Chen WJ; Ni LQ; Xu JY; Shen QY; Liang Y
    World J Surg Oncol; 2016 Feb; 14(1):30. PubMed ID: 26846782
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictors of metastasis to lymph nodes posterior to the right recurrent laryngeal nerve in differentiated thyroid carcinoma: A prospective study.
    Liu Z; Sun M; Xiao Y; Yang J; Zhang T; Zhao Y
    Asian J Surg; 2017 Jul; 40(4):270-277. PubMed ID: 26948300
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Surgical treatment of differentiated thyroid carcinoma and analysis of recurrence-related factors].
    Chen FJ; Li QL; Zeng ZY; Song M; Yang AK; Zhang Q
    Ai Zheng; 2004 Nov; 23(11):1311-6. PubMed ID: 15522180
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
    Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
    Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
    Jiang XL; Zhang H; Chen YL; Peng L
    Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
    [No Abstract]   [Full Text] [Related]  

  • 46. Selective lateral compartment neck dissection for thyroid cancer.
    Welch K; McHenry CR
    J Surg Res; 2013 Sep; 184(1):193-9. PubMed ID: 23816244
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The expression of sialic fibronectin correlates with lymph node metastasis of thyroid malignant neoplasmas.
    Takeyama H; Kyoda S; Okamoto T; Manome Y; Watanabe M; Kinoshita S; Uchida K; Sakamoto A; Morikawa T
    Anticancer Res; 2011 Apr; 31(4):1395-8. PubMed ID: 21508391
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Value of jugulo-omohyoid lymph nodes in predicting lateral cervical occult metastasis in patients with papillary thyroid carcinoma].
    An CM; Wang Y; Wang SX; Yin YL; Chen MQ; Xu ZG; Tang PZ; Li ZJ
    Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):207-210. PubMed ID: 28316221
    [No Abstract]   [Full Text] [Related]  

  • 49. [High aldehyde dehydrogenase 1A1 (ALDH1A1) expression correlated with risk of lymph node metastasis in papillary thyroid carcinoma].
    Yue C; Zhao X; Tian C; Jin Y; Liu H
    Zhonghua Bing Li Xue Za Zhi; 2015 Jul; 44(7):490-4. PubMed ID: 26705040
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nodal status of central lymph nodes as a negative prognostic factor for papillary thyroid carcinoma.
    Lee YS; Lim YS; Lee JC; Wang SG; Kim IJ; Son SM; Shin DH; Lee BJ
    J Surg Oncol; 2013 Jun; 107(7):777-82. PubMed ID: 23640873
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
    Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C
    BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Using ultrasound features and radiomics analysis to predict lymph node metastasis in patients with thyroid cancer.
    Li F; Pan D; He Y; Wu Y; Peng J; Li J; Wang Y; Yang H; Chen J
    BMC Surg; 2020 Dec; 20(1):315. PubMed ID: 33276765
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Analysis of risk factors for central lymph node metastasis in papillary thyroid microcarcinoma].
    Wang ZH; Zhang YJ; Fu GM; Chen YB
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jan; 54(1):12-17. PubMed ID: 30704163
    [No Abstract]   [Full Text] [Related]  

  • 54. Construction and validation of a nomogram for predicting lateral lymph node metastasis in pediatric and adolescent with differentiated thyroid carcinoma.
    Dan J; Tan J; Guo Y; Xu Y; Zhou L; Huang J; Yuan Z; Ai X; Li J
    Endocrine; 2024 Jun; 84(3):1088-1096. PubMed ID: 38367146
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Number of central lymph node metastasis for predicting lateral lymph node metastasis in papillary thyroid microcarcinoma.
    Zeng RC; Zhang W; Gao EL; Cheng P; Huang GL; Zhang XH; Li Q
    Head Neck; 2014 Jan; 36(1):101-6. PubMed ID: 23900787
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Number of positive central cervical lymph nodes for predicting lateral cervical lymph node metastasis in patients with papillary thyroid carcinoma].
    Cai Y; Chen E; Ni C; Li Q; Zeng R; Zhang X
    Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):628-31. PubMed ID: 26714606
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytomorphological factors and BRAF mutation predicting risk of lymph node metastasis in preoperative liquid-based fine needle aspirations of papillary thyroid carcinoma.
    Chung SY; Lee JS; Lee H; Park SH; Kim SJ; Ryu HS
    Acta Cytol; 2013; 57(3):252-8. PubMed ID: 23636013
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical and Pathologic Predictors of Lymph Node Metastasis and Recurrence in Papillary Thyroid Microcarcinoma.
    Siddiqui S; White MG; Antic T; Grogan RH; Angelos P; Kaplan EL; Cipriani NA
    Thyroid; 2016 Jun; 26(6):807-15. PubMed ID: 27117842
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
    Min JJ; Chung JK; Lee YJ; Jeong JM; Lee DS; Jang JJ; Lee MC; Cho BY
    Eur J Nucl Med; 2001 May; 28(5):639-45. PubMed ID: 11383871
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer.
    Melck A; Masoudi H; Griffith OL; Rajput A; Wilkins G; Bugis S; Jones SJ; Wiseman SM
    Ann Surg Oncol; 2007 Dec; 14(12):3403-11. PubMed ID: 17882495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.